6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
申请人:Hoffmann-La Roche Inc.
公开号:US09233978B2
公开(公告)日:2016-01-12
The invention provides novel compounds having the general formula:
wherein R1, R2, R3, R4, R5, R6, X, Y, W and n are as described herein, compositions including the compounds and methods of using the compounds.
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
申请人:HOFFMANN-LA ROCHE INC.
公开号:US20150252057A1
公开(公告)日:2015-09-10
The invention provides novel compounds having the general formula:
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X, Y, W and n are as described herein, compositions including the compounds and methods of using the compounds.